These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Understanding the Immunological Mechanisms of Mesenchymal Stem Cells in Allogeneic Transplantation: From the Aspect of Major Histocompatibility Complex Class I. Wang Y; Tian M; Wang F; Heng BC; Zhou J; Cai Z; Liu H Stem Cells Dev; 2019 Sep; 28(17):1141-1150. PubMed ID: 31215341 [TBL] [Abstract][Full Text] [Related]
11. The systemic cellular immune response against allogeneic mesenchymal stem cells is influenced by inflammation, differentiation and MHC compatibility: Cequier A; Vázquez FJ; Vitoria A; Bernad E; Fuente S; Serrano MB; Zaragoza MP; Romero A; Rodellar C; Barrachina L Front Vet Sci; 2024; 11():1391872. PubMed ID: 38957800 [TBL] [Abstract][Full Text] [Related]
12. Age- and dose-related effects on MSC engraftment levels and anatomical distribution in the central nervous systems of nonhuman primates: identification of novel MSC subpopulations that respond to guidance cues in brain. Isakova IA; Baker K; DuTreil M; Dufour J; Gaupp D; Phinney DG Stem Cells; 2007 Dec; 25(12):3261-70. PubMed ID: 17932418 [TBL] [Abstract][Full Text] [Related]
13. Production of Cytotoxic Antibodies After Intra-Articular Injection of Allogeneic Synovial Membrane Mesenchymal Stem Cells With and Without LPS Administration. Rosa GDS; Krieck AMT; Padula ET; Stievani FC; Rossi MC; Pfeifer JPH; Basso RM; Braz AMM; Golim MA; Alves ALG Front Immunol; 2022; 13():871216. PubMed ID: 35572507 [TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells: immune evasive, not immune privileged. Ankrum JA; Ong JF; Karp JM Nat Biotechnol; 2014 Mar; 32(3):252-60. PubMed ID: 24561556 [TBL] [Abstract][Full Text] [Related]
15. Immunological effects of the intraparenchymal administration of allogeneic and autologous adipose-derived mesenchymal stem cells after the acute phase of middle cerebral artery occlusion in rats. Yu Z; Wenyan T; Xuewen S; Baixiang D; Qian W; Zhaoyan W; Yinxiang Y; Suqing Q; Zuo L J Transl Med; 2018 Dec; 16(1):339. PubMed ID: 30518375 [TBL] [Abstract][Full Text] [Related]
16. Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. Nauta AJ; Westerhuis G; Kruisselbrink AB; Lurvink EG; Willemze R; Fibbe WE Blood; 2006 Sep; 108(6):2114-20. PubMed ID: 16690970 [TBL] [Abstract][Full Text] [Related]
17. Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice. Eliopoulos N; Stagg J; Lejeune L; Pommey S; Galipeau J Blood; 2005 Dec; 106(13):4057-65. PubMed ID: 16118325 [TBL] [Abstract][Full Text] [Related]
18. Safety of Allogeneic Mesenchymal Stem Cell Seeding of NeuraGen Nerve Guides in a Rabbit Model. Bedar M; van Wijnen AJ; Shin AY Tissue Eng Part C Methods; 2023 Feb; 29(2):43-53. PubMed ID: 36680753 [TBL] [Abstract][Full Text] [Related]
19. Direct imaging of immune rejection and memory induction by allogeneic mesenchymal stromal cells. Zangi L; Margalit R; Reich-Zeliger S; Bachar-Lustig E; Beilhack A; Negrin R; Reisner Y Stem Cells; 2009 Nov; 27(11):2865-74. PubMed ID: 19750539 [TBL] [Abstract][Full Text] [Related]
20. Modulation of human mesenchymal stem cell immunogenicity through forced expression of human cytomegalovirus us proteins. Soland MA; Bego MG; Colletti E; Porada CD; Zanjani ED; St Jeor S; Almeida-Porada G PLoS One; 2012; 7(5):e36163. PubMed ID: 22666319 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]